Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04684836 · ClinicalTrials.gov registry record
Comparative Effectiveness of Telemedicine in Primary Care
A clinical trial, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- 33,100
- Enrollment target
NCT04684836: Completed study, sponsored by Weill Medical College of Cornell University.
NCT04684836 is a clinical trial that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 33,100 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04684836 has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- 33,100 participants
- Enrollment target
Study Summary
Leveraging a natural experiment approach, the investigators will examine rapidly changing telemedicine and in-person models of care during and after the COVID-19 crisis to determine whether certain patients could safely choose to continue telemedicine or telemedicine-supplemented care, rather than return to in-person care.
Primary Outcome
Avoidable emergency department (ED) admissions will be obtained from claims data. The Effect of telemedicine on preventable emergency department admissions will be calculated using difference-in-differences methodology. The estimate coefficient of the difference-in-difference model will be reported.
Interventions
- OTHER Exposure to telemedicine, after the onset of the pandemic
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 33,100 participants |
| Start Date | 2021-03-15 |
| Est. Completion | 2022-04-01 |
What the finished NCT04684836 record still lists
NCT04684836 is an observational study that tracks outcomes without assigning an intervention. Its 33,100 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Exposure to telemedicine, after the onset of the pandemic is the first listed.
NCT04684836 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04684836 about?
NCT04684836 is a clinical study titled "Comparative Effectiveness of Telemedicine in Primary Care". Leveraging a natural experiment approach, the investigators will examine rapidly changing telemedicine and in-person models of care during and after the COVID-19 crisis to determine whether certain patients could safely choose to continue telemedicine or telemedicine-supplemented care, rather than r...
What is the current status of trial NCT04684836?
This trial is currently completed. The enrollment target is 33,100 participants. The study started on 2021-03-15. Estimated completion is 2022-04-01.
What interventions are being tested in trial NCT04684836?
The interventions under investigation include: Exposure to telemedicine, after the onset of the pandemic (OTHER).
Who is sponsoring clinical trial NCT04684836?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06145724 · 33,183 participants · NA
EnCoRe MoMS: Engaging Communities to Reduce Morbidity From Maternal Sepsis (Aim 1)
- NCT04477928 · 33,000 participants
General Population Level Estimation for Type 1 Diabetes Risk in Children During Routine Care Delivery
- NCT07282665 · 32,000 participants · Phase 3
A Study to Learn About a Clostridioides Difficile Vaccine in People 65 Years of Age and Older
- NCT03720613 · 34,532 participants
Risk of Major Adverse Cardiovascular Events for Naldemedine & Other Medications for Opioid Induced Constipation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI